INTRODUCTION
============

Standard tuberculosis (TB) treatment is highly efficacious, but curing TB requires a long treatment duration and many drugs ([@B1]), which may lead to non-adherence to a full course of anti-TB treatment. The WHO 2013 revised definitions and reporting defines default from TB treatment as "lost to follow-up," i.e., a TB patient who did not start treatment or whose treatment was interrupted for 2 consecutive months or more ([@B2]). Defaulted patients have higher risks of a second default, multidrug-resistant TB development, and mortality ([@B3][@B4][@B5]). Patients who default in high-burden settings also have a higher rate of subsequent smear-positive TB, suggesting a high risk of transmission to other persons ([@B6]). Therefore, knowing the risk factors for default is important for the effectiveness of TB control program.

Risk factors for treatment discontinuation have been widely investigated, especially in countries where human immunodeficiency virus is endemic and developing countries ([@B7][@B8][@B9][@B10][@B11][@B12]). In contrast to most developed countries, which have low incidences of TB, new cases in Korea have plateaued at approximately 100 per 100,000 persons over the past decade ([@B13]). Thus, TB remains a major health concern and incurs a large burden on public health despite the well-appointed medical delivery system in Korea. Therefore, this study investigated the individual sociodemographic and clinical characteristics of defaulted patients and identified the risk factors associated with default from TB treatment.

MATERIALS AND METHODS
=====================

Study subjects
--------------

This single-center case--control study retrospectively reviewed the data of 2,072 patients aged more than 18 years who were registered and treated for pulmonary TB or extrapulmonary TB (EPTB) at Chonnam National University Hospital from January 2010 to December 2014. TB was diagnosed on the basis of *Mycobacterium tuberculosis* identification by culture or polymerase chain reaction (PCR) from clinical specimens or clinical, radiological, or histological findings compatible with TB and responses to TB treatment. All TB patients received TB health education as well as monitoring for drug compliance and adverse drug reactions during treatment by specially trained nurses who participated in the Public--Private Mix (PPM) project for TB control in Korea.

TB drugs were self-administered with the support of trained PPM nurses during treatment. At each clinical visit, treatment adherence was assessed by asking patients about their drug intake and checking the remnant tablets of the previously prescribed regimen.

Data collection and definitions
-------------------------------

Once TB was diagnosed at our institute or a TB patient was transferred from another clinic, the patient was enrolled in the national TB registry. Physicians reported the patients' data to the registry, and PPM nurses entered the data into registry database and updated it as necessary. The following patient information was obtained through electronic medical records: baseline clinical data, comorbidities, history and outcome of previous TB treatment, radiologic findings at diagnosis, microbiological characteristics at diagnosis (acid-fast bacilli stain, mycobacterial culture, and PCR in clinical specimens; drug resistance; and culture conversion after treatment), and side effects during TB treatment. Employment was categorized as "regular" if the patient was employed in a year-round position or was a full-time student and "irregular or unemployed" if the patient had a seasonal or day-labor position ([@B12]). Education was classified into three groups according to the highest level the patient completed: elementary school, middle or high school, and college or university education was classified as primary, secondary, and post-secondary, respectively. Income was categorized on the basis of the average monthly income of the patient or their household in Korea with reference to national statistics (Korean Statistical Information Service, <http://kosis.kr>) according to a cut-off corresponding to the fourth quartile. Health insurance was categorized into two groups on the basis of qualification for national health insurance. Public assistance was applicable to people who were unable to support their family. In underlying diseases, chronic pulmonary disease was defined as a non-infectious chronic pulmonary disease such as chronic obstructive pulmonary disease and asthma. Chronic kidney disease was defined as a disease causing a progressive loss in renal function. Chronic cardiac disease was defined as a disease which needed a long term use of cardiac medications such as coronary artery disease, valvular heart disease, cardiomyopathy, and cardiac arrhythmias. Chronic liver disease was defined as a disease casing progressive destruction and regeneration of liver parenchyma such as chronic viral hepatitis, alcoholic liver disease, and liver cirrhosis.

Patients were classified into two groups according to treatment outcome ([@B2]). The case group comprised defaulters, i.e., TB patients who did not start treatment or whose treatment was interrupted for 2 consecutive months or more. Meanwhile, the control group comprised non-defaulters who had been cured or completed treatment. Patients with TB-related death or those who were transferred out were excluded from the control group.

To track defaulters, PPM nurses tried to contact all of the listed patients by telephone and ascertained individual clinical and socioeconomic data. For non-defaulters, the data were obtained by one or two in-person interviews by PPM nurses during follow-up at the outpatient department. Questionnaires were administered to collect information about personal details, disease perception (i.e., TB), and causes of default. The questions were selected from among several factors found to be significantly associated with default in previous studies ([@B7][@B8][@B9][@B10][@B12]). Disease stigma was defined as feeling ashamed to have TB, trying to hide from or disclose to others, or attempting to be isolated ([@B8][@B9]). Incorrect perception or information about the disease was defined as a patient's lack of adequate knowledge and education about TB or their recent disease status, such as the efficacy of anti-TB treatment, possibility of feeling better or being cured, and treatment duration ([@B7][@B8]). A low level of satisfaction with the clinic or doctors reflected poor healthcare worker attitude towards patients, long waiting times at the clinic, or lack of opportunity to express feelings ([@B8][@B10]).

Statistical analysis
--------------------

All data are expressed as median (interquartile range \[IQR\]) or numbers and percentages. Intergroup comparisons were performed using the Mann--Whitney *U*-test for continuous variables, and Pearson's *χ* ^2^ test or Fisher's exact test for categorical variables. We evaluated trends using the *χ* ^2^ test for trends. Multivariate analysis was performed to determine the predictors of default from TB treatment. Possible predictors found to be significant in univariate analysis were entered into binary logistic regression. The level of significance was set at *P* \< 0.05.

We planned a study of independent cases and controls with two controls per case. Data of the entire population with TB at our clinic indicate the probability of default (i.e., default rate) was 0.049. If the true odds ratio for disease in exposed subjects relative to unexposed subjects is 5, we would need to study 49 case patients and 98 control patients to be able to reject the null hypothesis that this odds ratio equals 1 with a probability (i.e., power) of 0.8. We tried to contact all 102 defaulted patients using telephone, but we could connect 58 patients. Of these patients, 46 patients agreed to telephone interview. Ultimately, we recruited 46 cases and randomly selected 100 controls who were eligible for personal interview and regularly followed up. The type I error probability associated with this test of this null hypothesis is 0.05.

Ethics statement
----------------

Permission to review and publish patient records was obtained from the institutional review board of Chonnam National University Hospital (IRB No. CNUH-2014-260). Informed consent was obtained from patients personally, and confidentiality and anonymity were assured. In cases of defaulters who would not or could not visit the hospital, assistants asked for consent to participate in this study by telephone.

RESULTS
=======

Patient characteristics
-----------------------

Among 2,072 patients with TB treated at Chonnam National University Hospital from January 2010 to December 2014, 102 were defaulted from treatment, giving a default rate of 4.9%. Among them, 46 defaulters were assigned to the case group, and 100 patients were randomly selected as controls.

Regarding sociodemographic characteristics, a larger proportion of defaulters had low income (\< 2,000 US dollars per month) than controls. Other factors such as body mass index, smoking, alcohol, employment, marriage, education, insurance, and hospital accessibility did not differ significantly between groups ([Table 1](#T1){ref-type="table"}).

###### Sociodemographic characteristics of the control and default groups

![](jkms-31-254-i001)

  -------------------------------------------------------------------------------------------------------
  Characteristics                    Total\             Control\           Default\           *P* value
                                     (n = 146)          (n = 100)          (n = 46)           
  ---------------------------------- ------------------ ------------------ ------------------ -----------
  Age, yr                            52.5 (31.0-70.0)   53.5 (31.0-70.5)   52.0 (30.0-69.0)   0.745

  Sex                                                                                         0.643

   Female                            58 (39.7)          41 (41.0)          17 (37.0)          

   Male                              88 (60.3)          59 (59.0)          29 (63.0)          

  BMI, kg/m^2^                       21.0 (19.5-23.2)   20.4 (19.2-22.3)   21.9 (20.3-24.5)   0.062

   \< 18.5                           17 (11.6)          15 (15.0)          2 (4.3)            

   ≥ 18.5                            130 (88.4)         85 (85.0)          44 (95.7)          

  Smoking                                                                                     0.086

   Never smoker                      66 (45.2)          50 (50.0)          16 (34.8)          

   Ever smoker                       80 (54.8)          50 (50.0)          30 (65.2)          

  Alcohol consumption                                                                         0.219

   No                                90 (61.6)          65 (65.0)          25 (54.3)          

   Yes                               56 (38.4)          35 (35.0)          21 (45.7)          

  Herbal medication                  9 (6.2)            6 (6.0)            3 (6.5)            1.000

  Employment                                                                                  0.245

   Regular                           69 (47.3)          44 (44.0)          25 (54.3)          

   Irregular or unemployed           77 (52.7)          56 (56.0)          21 (45.7)          

  Marriage                                                                                    0.640

   Married                           96 (65.8)          67 (67.0)          29 (63.0)          

   Single/divorced/bereaved          50 (34.2)          33 (33.0)          17 (37.0)          

  Family members                                                                              0.951

   Living together                   117 (80.1)         80 (80.0)          37 (80.4)          

   Living alone                      29 (19.9)          20 (20.0)          9 (19.6)           

  Education                          144                98                 46                 0.673

   Primary                           45 (31.3)          32 (32.7)          13 (28.3)          

   Secondary                         20 (13.9)          12 (12.2)          8 (17.4)           

   Post-secondary                    79 (54.9)          54 (55.1)          25 (54.3)          

  Income/month                       137                95                 42                 0.015

   \< 2,000 US dollars               102 (74.5)         65 (68.4)          37 (88.1)          

   ≥ 2,000 US dollars                35 (25.5)          30 (31.6)          5 (11.9)           

  Insurance                                                                                   0.549

   National health insurance         132 (90.4)         89 (89.0)          43 (93.5)          

   Public assistance                 14 (9.6)           11 (11.0)          3 (6.5)            

  Distance from home to clinic, km   24.3 (7.6-85.3)    25.2 (11.2-88.0)   20.4 (6.5-75.3)    0.190

   \< 50                             85 (58.2)          57 (57.0)          28 (60.9)          0.258

   50-100                            38 (26.0)          24 (24.0)          14 (30.4)          

   \> 100                            23 (15.8)          19 (19.0)          4 (8.7)            
  -------------------------------------------------------------------------------------------------------

Values are expressed as median (interquartile range) or number of patients (%). BMI, Body mass index.

The median (IQR) time from treatment initiation to default was 101 (35--185) days. Regarding clinical characteristics, patients treated by a non-pulmonologist and patients with EPTB had a significantly higher default rate. Patients with a history of treatment for TB or former default also had a significantly higher default rate ([Table 2](#T2){ref-type="table"}). Adverse drug reactions predominantly affected the skin (e.g., pruritus, rash, and acne) and gastrointestinal system (e.g., nausea, vomiting, and anorexia). However, there were no differences in adverse drug reactions between groups ([Table 3](#T3){ref-type="table"}).

###### Clinical and microbiologic characteristics of the control and default groups

![](jkms-31-254-i002)

  ----------------------------------------------------------------------------------------
  Parameters                   Total\          Control\        Default\        *P* value
                               (n = 146)       (n = 100)       (n = 46)        
  ---------------------------- --------------- --------------- --------------- -----------
  Attending physician                                                          \< 0.001

   Non-pulmonologist           27 (18.5)       7 (7.0)         20 (43.5)       

   Pulmonologist               119 (81.5)      93 (93.0)       26 (56.5)       

  Underlying diseases                                                          

   Diabetes                    21 (14.4)       12 (12.0)       9 (19.6)        0.226

   Chronic liver disease       17 (11.6)       12 (12.0)       5 (10.9)        0.843

   Chronic cardiac disease     27 (18.5)       17 (17.0)       10 (21.7)       0.493

   Chronic kidney disease      3 (2.1)         2 (2.0)         1 (2.2)         1.000

   Cerebrovascular disease     10 (6.8)        6 (6.0)         4 (8.7)         0.725

   Malignancy                  8 (5.5)         5 (5.0)         3 (6.5)         0.707

   Chronic pulmonary disease   10 (6.8)        5 (5.0)         5 (10.9)        0.288

   Psychological disorder      2 (1.4)         1 (1.0)         1 (2.2)         0.532

  Previous treatment           36 (24.7)       19 (19.0)       17 (37.0)       0.019

   Number of treatments        1.0 (1.0-1.0)   1.0 (1.0-1.0)   1.0 (1.0-1.0)   0.071

   Duration, months            6.0 (3.5-8.5)   6.0 (5.0-9.5)   6.0 (2.0-8.0)   0.126

  Former defaulter             9 (6.2)         2 (2.0)         7 (15.2)        0.005

  EPTB                                                                         

   Combined                    59 (40.4)       34 (34.0)       25 (54.3)       0.020

   Alone                       25 (17.1)       6 (6.0)         19 (41.3)       \< 0.001

  Radiologic findings          145             100             45              

   Cavity                      28 (19.3)       19 (19.0)       9 (20.0)        0.888

   Extent                      123             94              29              0.559

    Localized                  90 (73.2)       70 (74.5)       20 (69.0)       

    Bilateral disease          33 (26.8)       24 (25.5)       9 (31.0)        

  AFB smear                    137             100             37              0.163

    Positive                   42 (30.7)       34 (34.0)       8 (21.6)        

    Negative                   95 (69.3)       66 (66.0)       29 (78.4)       

  AFB culture                  134             96              38              0.085

    Positive                   89 (66.4)       68 (70.8)       21 (55.3)       

    Negative                   45 (33.6)       28 (29.2)       17 (44.7)       
  ----------------------------------------------------------------------------------------

Values are expressed as median (interquartile range) or number of patients (%). AFB, acid-fast bacilli; EPTB, extrapulmonary tuberculosis.

###### Drug resistance, therapeutic characteristics, adverse drug reactions, and perceptions of disease in the control and default groups
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  ---------------------------------------------------------------------------------------------
  Variables                                    Total\       Control\    Default\    *P* value
                                               (n = 146)    (n = 100)   (n = 46)    
  -------------------------------------------- ------------ ----------- ----------- -----------
  Resistance                                   90           75          15          

   Susceptible                                 71 (78.9)    58 (77.3)   13 (86.7)   1.000

   Non-MDR drug resistance                     9 (10.0)     8 (10.7)    1 (6.7)     

   MDR                                         10 (11.1)    9 (12.0)    1 (6.7)     

  Admission during intensive treatment phase   70 (47.9)    52 (52.0)   18 (39.1)   0.148

  Regimen                                                                           0.371

   With pyrazinamide                           132 (90.4)   92 (92.0)   40 (87.0)   

   Without pyrazinamide                        14 (9.6)     8 (8.0)     6 (13.0)    

  Improvement of symptoms after treatment      137          98          39          

   Improved                                    96 (70.1)    71 (72.4)   25 (64.1)   0.336

   Not improved                                41 (29.9)    27 (27.6)   14 (35.9)   

  Adverse drug reactions                       144          100         44          

   Present                                     82 (56.9)    58 (58.0)   24 (54.5)   0.700

   Gastrointestinal                            39 (27.3)    28 (28.0)   11 (25.0)   0.766

   Liver                                       19 (13.2)    13 (13.0)   6 (13.6)    0.917

   Skin                                        41 (28.5)    30 (30.0)   11 (25.0)   0.540

   Optic                                       8 (5.6)      8 (8.0)     0 (0.0)     0.106

   Joint                                       9 (6.3)      7 (7.0)     2 (4.5)     0.722

   Drug fever                                  5 (3.5)      2 (2.0)     3 (6.8)     0.167

   Peripheral neuropathy                       9 (6.3)      7 (7.0)     2 (4.5)     0.722

   Others^\*^                                  7 (4.9)      6 (6.0)     1 (2.3)     

  Disease perception                           139          93          46          

   Disease stigma                              59 (42.4)    57 (61.3)   2 (4.3)     \< 0.001

   Incorrect perception or information         61 (43.9)    42 (45.2)   19 (41.3)   0.666
  ---------------------------------------------------------------------------------------------

Values are expressed as median (interquartile range) or number of patients (%). MDR, multidrug resistant.

\*Includes headache (n = 3), dizziness (n = 2), tinnitus (n = 1), and cytopenia (n = 1).

The results regarding disease perception are shown in [Table 3](#T3){ref-type="table"}. Interestingly, most defaulters did not feel stigma about their disease, whereas more than half of non-defaulters did.

The most common cause of treatment default according to patients' personal opinions was incorrect perception or information about their disease (19/46, 41.3%) and side effects of anti-TB treatment (19/46, 41.3%). Poor treatment tolerability such as work interference with adherence or unwillingness to taking medicine (12/46, 26.1%) and low level of satisfaction with the clinic or doctors (5/46, 10.9%) were less common reasons.

Predictors of treatment default
-------------------------------

Significant risk factors for default in univariate analysis, including low income (\< 2,000 US dollars/month), treatment by a non-pulmonologist, history of previous treatment, former default, combined EPTB, and absence of TB stigma, were included in multivariate analysis. In multivariate analysis, low income (adjusted odd ratio \[aOR\]: 5.246, 95% confidence interval \[CI\]: 1.249--22.029, *P* = 0.024), treatment by a non-pulmonologist (aOR: 14.567, 95% CI: 3.260--65.089, *P* \< 0.001), former defaulters (aOR: 33.226, 95% CI: 2.658--415.309, *P* = 0.007), and absence of TB stigma (aOR: 46.299, 95% CI: 8.078--265.365, *P* \< 0.001) were independent predictors of default from TB treatment.

DISCUSSION
==========

This is the first study to evaluate the predictors of default from TB treatment in Korea, which is a high-income country with an intermediate TB incidence. The default rate during TB treatment varies with respect to the condition of enrolled patients, treatment, healthcare system, patients' knowledge and attitude about TB, and socioeconomic status ([@B9][@B10]). The default rate in the present study was 4.9%, which is lower than that in a previous study in Korea (7.3%) ([@B14]); however, that study was performed in 2008, before the implementation of the PPM project in Korea. The PPM project, which started in 2009, has increased the treatment success rate and decreased losses to follow-up ([@B15][@B16]). All patients in the present study received TB health education and monitoring by specially trained nurses participating in the PPM project, which might have reduced the default rate. Since starting the PPM project at our institute in 2010, the default rate has decreased significantly from 6.2% in 2010 to 2.9% in 2014 (*P*~trend~ = 0.003), which might be due to greater nurses' experience with proper education and monitoring of TB patients.

Regarding the timing of default, our finding that the median time from treatment start to default was 101 days is consistent with previous studies including a systematic review reporting that the majority of defaulters completed the two-month intensive phase of treatment ([@B17]). This might be related to rapid symptom improvement after starting TB treatment. In the present study, more than half of patients who defaulted had experienced symptom improvement when they defaulted and there was no difference between the default and control groups with respect to the rate of symptom improvement, even after treatment completion in the control group.

Higher default rates and worse outcomes in patients with low income have been reported in previous study ([@B7]). The present study also shows that a larger proportion of defaulters had lower income than controls. Nevertheless, more than two thirds of controls patients had a low income \< 2,000 US dollars per month. Therefore, the results not only demonstrate the importance of economic status in default from TB treatment, but also the overall poor economic status of TB patients in Korea.

Interestingly, TB treatment by a non-pulmonologist was an independent predictor of default. Accordingly, medical personnel who have low motivation to treat TB patients might increase the default rate ([@B11]). Pulmonologists might communicate with patients more effectively, which could decrease the default rate. Another possible explanation for this finding is that in Korea including our institute, there has been trend of treating patients with EPTB by non-pulmonologists and with pulmonary TB by pulmonologists, respectively. The diagnosis of EPTB can be elusive, requiring a high index of suspicion. Moreover, cases have a low probability of culturing *M. tuberculosis*. Furthermore, the standards for the assessment of therapeutic response tend to be uncertain. All of these factors might increase the risk of default in patients with EPTB. In the present study, patients with EPTB had a higher default rate than patients with pulmonary TB in univariate analysis, although this association lost statistical significance in multivariate analysis.

Former default status was an independent predictor of default in the present study, which has also been reported in previous studies in different settings ([@B7][@B8]). Therefore, history of TB treatment and treatment outcome could be important when determining patients' risk of default from TB treatment.

TB stigma is reported to delay TB diagnosis and decrease treatment compliance. Furthermore, disease stigma is reported to be a risk factor for default ([@B8][@B18]). In contrast, some studies report that TB stigma is a predictor of treatment adherence, and TB patients who were ashamed of TB contacted healthcare facilities early ([@B9][@B19]). In the present study, absence of disease stigma was an independent predictor of treatment default; therefore, TB stigma might motivate patients to receive TB treatment, thus increasing adherence to TB treatment.

The predominant causes of default were incorrect perception or information about TB and experience of adverse events due to TB drugs. Concordantly, studies in other countries report similar causes of default despite socioeconomic and cultural differences ([@B7][@B8]) as well as in drug-resistant TB patients ([@B20]). One study reports the reasons for completing treatment include desire to be cured (93%), doctor's advice to complete treatment (41%), not wanting to transmit TB to others (24%), and fear for one's health (20%) ([@B21]). Therefore, patients' better awareness and fewer misconceptions about TB could decrease the default rate. Education about TB should be tailored to individual patients' needs and continued throughout the course of treatment in combination with awareness and monitoring of the side effects of drugs.

This study has several limitations that should be mentioned. First, this study was performed in a single center in Korea, which may limit the generalizability of our findings to other countries and different settings. Second, we could not investigate all 102 defaulters; we only enrolled the 46 patients available for interviews. Therefore, this may have caused a selection bias in the case group. Third, only questionnaires filled in by patients and not physicians were used in the assessment of causes of default; this might influence the objectivity of reasons for default and might have resulted in other causes linked with important clinical manifestations being overlooked.

In summary, TB patients with absence of disease stigma, being treated by a non-pulmonologist, who have previously defaulted, and have low income should be carefully monitored during TB treatment in Korea in order to avoid treatment default. Health departments should develop effective measures to prevent treatment default in order to ensure therapy completion and improve treatment outcomes.
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